Literature DB >> 17384985

Primary central nervous system lymphoma secretes monocyte chemoattractant protein 1.

Ryuhei Kitai1, Kazuyo Ishisaka, Kazufumi Sato, Takahiro Sakuma, Takahiro Yamauchi, Yoshiaki Imamura, Hideki Matsumoto, Toshihiko Kubota.   

Abstract

The majority of primary central nervous system lymphomas (PCNSL) are diffuse large B-cell lymphomas. Histologically, reactive T lymphocytes and mono-histiocytic cells are found within PCNSL tissue. To clarify the mechanisms of the cellular infiltration, the presence of monocyte chemoattractant protein (MCP-1) was investigated in biopsy samples of 19 cases of PCNSL by means of immunohistochemical staining, double staining with a confocal laser microscope, and Western blot analysis. MCP-1 expression was observed in all PCNSL immunohistochemically. Western blot analysis showed that the concentration of MCP-1 in PCNSL was as high as that in a metastatic brain tumor. In normal brain tissue, MCP-1 was not detected. Confocal laser microscope revealed MCP-1 signals were present in the cells with CD20, a B-cell marker. We concluded that lymphoma cells produced MCP-1, which is an additional cytokine involved in the pathogenesis of PCNSL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384985     DOI: 10.1007/s00795-006-0350-7

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  23 in total

1.  The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.

Authors:  M G Luciani; A Stoppacciaro; G Peri; A Mantovani; L P Ruco
Journal:  Mol Pathol       Date:  1998-10

2.  Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system.

Authors:  J M Baehring; C Henchcliffe; C J Ledezma; R Fulbright; F H Hochberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

3.  Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment.

Authors:  Tsuyoshi Kuroda; Yasuhiko Kitadai; Shinji Tanaka; Xiaoqin Yang; Naofumi Mukaida; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

4.  Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.

Authors:  Katherine S Panageas; Elena B Elkin; Lisa M DeAngelis; Leah Ben-Porat; Lauren E Abrey
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

5.  Production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha by inflammatory granuloma fibroblasts.

Authors:  N W Lukacs; S W Chensue; R E Smith; R M Strieter; K Warmington; C Wilke; S L Kunkel
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

6.  Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes.

Authors:  F Colotta; A Borré; J M Wang; M Tattanelli; F Maddalena; N Polentarutti; G Peri; A Mantovani
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

7.  Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids.

Authors:  V B Antony; S W Godbey; S L Kunkel; J W Hott; D L Hartman; M D Burdick; R M Strieter
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

8.  Expression of monocyte chemotactic protein-1 in human melanoma in vivo.

Authors:  D T Graves; R Barnhill; T Galanopoulos; H N Antoniades
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

9.  Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease.

Authors:  L Mazzucchelli; C Hauser; K Zgraggen; H E Wagner; M W Hess; J A Laissue; C Mueller
Journal:  J Pathol       Date:  1996-02       Impact factor: 7.996

10.  Cytokine-induced expression of mRNAs for chemotactic factors in human synovial cells and fibroblasts.

Authors:  P A Bédard; E E Golds
Journal:  J Cell Physiol       Date:  1993-02       Impact factor: 6.384

View more
  7 in total

1.  Gene selection using iterative feature elimination random forests for survival outcomes.

Authors:  Herbert Pang; Stephen L George; Ken Hui; Tiejun Tong
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2012 Sep-Oct       Impact factor: 3.710

2.  CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.

Authors:  Aurélien Viaccoz; François Ducray; Yannick Tholance; Gleicy Keli Barcelos; Laure Thomas-Maisonneuve; Hervé Ghesquières; David Meyronet; Isabelle Quadrio; Stéphanie Cartalat-Carel; Guy Louis-Tisserand; Emmanuel Jouanneau; Jacques Guyotat; Jérôme Honnorat; Armand Perret-Liaudet
Journal:  Neuro Oncol       Date:  2015-05-25       Impact factor: 12.300

Review 3.  Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy.

Authors:  Gregory P Takacs; Joseph A Flores-Toro; Jeffrey K Harrison
Journal:  Pharmacol Ther       Date:  2020-12-11       Impact factor: 12.310

4.  Brain stereotactic biopsy flow cytometry for central nervous system lymphoma characterization: advantages and pitfalls.

Authors:  Iole Cordone; Serena Masi; Mariantonia Carosi; Antonello Vidiri; Francesco Marchesi; Mirella Marino; Stefano Telera; Alessia Pasquale; Andrea Mengarelli; Laura Conti; Edoardo Pescarmona; Andrea Pace; Carmine M Carapella
Journal:  J Exp Clin Cancer Res       Date:  2016-08-27

5.  Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma.

Authors:  Yoshinobu Takahashi; Takahiro Sawada; Toshiaki Akahane; Yumiko Kawase; Hidetoshi Ikeda; Keishi Makino; Hideo Nakamura; Takuichiro Hide; Shigetoshi Yano; Naoya Hashimoto; Hajime Kamada
Journal:  Oncol Lett       Date:  2017-05-04       Impact factor: 2.967

6.  The diagnostic role and dynamic changes in cerebrospinal fluid neopterin during treatment of patients with primary central nervous system lymphoma.

Authors:  Mingying Geng; He Xiao; Jiaqi Liu; Yang Song; Ping Fu; Xing Cheng; Jinwei Zhang; Ge Wang
Journal:  Cancer Med       Date:  2018-07-07       Impact factor: 4.452

7.  Influence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.

Authors:  Claire Galand; Sabrina Donnou; Thierry Jo Molina; Wolf Herman Fridman; Sylvain Fisson; Catherine Sautès-Fridman
Journal:  Front Immunol       Date:  2012-05-04       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.